-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
8 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$31.43 M
Dyne Therapeutics, Inc. Insider Transactions
Dyne Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
McNeill Jonathan
Chief Business Officer |
Sell | 34,663 @ $25.46 | $882,520 | 196,521 | 03/08/2024 | 03/13/2024 | |
|
McNeill Jonathan
Chief Business Officer |
Sell | 54,648 @ $26.72 | $1.46 M | 141,873 | 03/08/2024 | 03/13/2024 | |
|
McNeill Jonathan
Chief Business Officer |
Sell | 689 @ $27.31 | $18,817 | 141,184 | 03/08/2024 | 03/13/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 30,755 @ $25.31 | $778,409 | 177,452 | 03/08/2024 | 03/12/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 55,208 @ $26.72 | $1.48 M | 122,244 | 03/08/2024 | 03/12/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 289 @ $27.33 | $7,898 | 121,955 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 202,238 @ $25.30 | $5.12 M | 715,490 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 160,670 @ $26.72 | $4.29 M | 554,820 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 435 @ $27.38 | $11,910 | 554,385 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 9,086 @ $25.85 | $234,873 | 554,385 | 03/07/2024 | 03/11/2024 | |
|
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 2,373 @ $25.85 | $61,342 | 154,433 | 03/07/2024 | 03/11/2024 | |
| Sell | 1,591 @ $25.85 | $41,127 | 186,291 | 03/07/2024 | 03/11/2024 | ||
|
Farwell Wildon
Chief Medical Officer |
Sell | 8,364 @ $25.80 | $215,791 | 154,732 | 03/07/2024 | 03/11/2024 | |
|
Farwell Wildon
Chief Medical Officer |
Sell | 1,557 @ $26.20 | $40,793 | 153,175 | 03/07/2024 | 03/11/2024 | |
|
McNeill Jonathan
Chief Business Officer |
Sell | 2,434 @ $25.85 | $62,919 | 141,184 | 03/07/2024 | 03/11/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 2,273 @ $25.85 | $58,757 | 121,955 | 03/07/2024 | 03/11/2024 | |
|
Rhodes Jason P
Director |
Sell | 29,435 @ $30.05 | $884,522 | 1,458,691 | 03/01/2024 | 03/05/2024 | |
|
Rhodes Jason P
Director |
Sell | 17,099 @ $30.05 | $513,825 | 847,388 | 03/01/2024 | 03/05/2024 | |
|
Atlas Venture Opportunity Fund I, L.P.
10 percent owner |
Sell | 29,435 @ $30.05 | $884,522 | 1,458,691 | 03/01/2024 | 03/05/2024 | |
|
Atlas Venture Opportunity Fund I, L.P.
10 percent owner |
Sell | 17,099 @ $30.05 | $513,825 | 847,388 | 03/01/2024 | 03/05/2024 |
Dyne Therapeutics, Inc. Frequently Asked Questions
-
Who is on Dyne Therapeutics, Inc.'s Insider Roster?
The list of insiders at Dyne Therapeutics, Inc. includes McNeill Jonathan, Brumm Joshua T, Atlas Venture Opportunity Fund I, L.P., Rhodes Jason P, Scalzo Richard William, Farwell Wildon, HIGH SUSANNA GATTI, Beskrovnaya Oxana.
-
How much insider selling is happening at Dyne Therapeutics, Inc.?
Insiders have sold a total of 1.13 M Dyne Therapeutics, Inc. shares in the last 12 months for a total of 31.43 M sold.
-
Which Dyne Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Dyne Therapeutics, Inc. shares in the last 12 months: McNeill Jonathan ($3.87 M), Brumm Joshua T ($14.26 M), Atlas Venture Opportunity Fund I, L.P. ($1.40 M), Rhodes Jason P ($1.40 M), Scalzo Richard William ($2.55 M), Farwell Wildon ($473,404), HIGH SUSANNA GATTI ($6.22 M), Beskrovnaya Oxana ($1.26 M),